Research ArticleArticle
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry
Philip J. Mease, Tamara Lesperance, Mei Liu, David H. Collier, Marc Mason, Sabrina Deveikis and Neil A. Accortt
The Journal of Rheumatology January 2017, jrheum.160343; DOI: https://doi.org/10.3899/jrheum.160343
Philip J. Mease
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Tamara Lesperance
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Mei Liu
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
David H. Collier
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Marc Mason
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Sabrina Deveikis
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Neil A. Accortt
From the Swedish Medical Center and University of Washington, Seattle, Washington; Amgen Inc., Thousand Oaks, California; Corrona LLC, Southborough, Massachusetts, USA. Sponsored by Corrona LLC and funded by Amgen Inc. The Corrona Rheumatoid Arthritis registry has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen Inc., AstraZeneca, Bristol-Myers Squibb, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. P.J. Mease has received research grants from AbbVie, Amgen Inc., Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer, and UCB; consulting fees from AbbVie, Amgen Inc., Bristol-Myers Squibb, Corrona, Crescendo, Eli Lilly, Merck, Novartis, Pfizer, and UCB; and speaker fees from AbbVie, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Crescendo, Eli Lilly, Pfizer, and UCB. T. Lesperance is a contractor for and has received salary from Amgen Inc. M. Liu is an employee of Corrona LLC. D.H. Collier is an employee and stockholder of Amgen Inc. M. Mason is an employee of Corrona LLC. S. Deveikis is an employee of Corrona LLC. N.A. Accortt is an employee and stockholder of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; T. Lesperance, MPH, Amgen Inc.; M. Liu, PhD, Corrona LLC; D.H. Collier, MD, Amgen Inc.; M. Mason, PhD, Corrona LLC; S. Deveikis, MPH, Corrona LLC; N.A. Accortt, PhD, Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication October 21, 2016.
Article Figures & Data
Additional Files
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry
Philip J. Mease, Tamara Lesperance, Mei Liu, David H. Collier, Marc Mason, Sabrina Deveikis, Neil A. Accortt
The Journal of Rheumatology Jan 2017, jrheum.160343; DOI: 10.3899/jrheum.160343
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry
Philip J. Mease, Tamara Lesperance, Mei Liu, David H. Collier, Marc Mason, Sabrina Deveikis, Neil A. Accortt
The Journal of Rheumatology Jan 2017, jrheum.160343; DOI: 10.3899/jrheum.160343